Undetectable<i>RAS</i>-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With<i>RAS</i>-Mutant Metastatic Colorectal Cancer

Abstract

Patients with <i>RAS</i>-mt mCRC whose plasma biopsies contained <i>RAS</i>-wt could benefit from cetuximab-based therapy, a hypothesis to be tested in a prospective randomized trial.